Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis
暂无分享,去创建一个
A. Naiki‐Ito | Keitaro Iida | T. Naiki | S. Nozaki | T. Nagai | T. Etani | R. Ando | N. Kawai | T. Yasui | S. Hamamoto | Hiroki Kubota | Yosuke Sugiyama | T. Isobe | Yusuke Noda | Nobuhiko Shimizu | N. Tomiyama | Rika Banno | K. Iida | Y. Sugiyama